
Quest Diagnostics, Inc (DGX) Stock: What the Analysts are Saying
Quest Diagnostics, Inc (NYSE: DGX) has a price-to-earnings ratio that is above its average at 22.53x. The stock has a 36-month beta value of 0.52.
Quest Diagnostics, Inc (NYSE: DGX) has a price-to-earnings ratio that is above its average at 22.53x. The stock has a 36-month beta value of 0.52.
Quest Diagnostics, Inc (NYSE: DGX)’s stock price has soared by 6.78 in relation to previous closing price of 161.86. Nevertheless, the company has seen a
Quest Diagnostics, Inc (NYSE: DGX) has seen a decline in its stock price by -1.65 in relation to its previous close of 167.23. However, the
Quest Diagnostics, Inc (NYSE: DGX)’s stock price has plunge by -0.13relation to previous closing price of 164.06. Nevertheless, the company has seen a -3.97% plunge
The stock of Quest Diagnostics, Inc (DGX) has gone up by 2.79% for the week, with a -0.80% drop in the past month and a
The price-to-earnings ratio for Quest Diagnostics, Inc (NYSE: DGX) is 21.57x, which is above its average ratio. Moreover, the 36-month beta value for DGX is
Quest Diagnostics, Inc (NYSE: DGX)’s stock price has dropped by -3.53 in relation to previous closing price of 172.45. Nevertheless, the company has seen a
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.